Urinary Catheters Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Intermittent Catheters, Foley/ Indwelling Catheters, External Catheters), By Application (Benign Prostate Hyperplasia & Prostate Surgeries, Urinary Incontinence, Spinal Cord Injury, Others), By Type (Coated Catheters, Uncoated Catheters), By End User (Hospital, Clinics, Long-Term Care Facilities, Others), By Region, & Competition, 2021-2031F

Market Overview

The Global Urinary Catheters Market is projected to grow from USD 5.96 Billion in 2025 to USD 8.37 Billion by 2031 at a 5.82% CAGR. Urinary catheters are medical devices inserted into the bladder to facilitate urine drainage, primarily utilized for patients experiencing urinary incontinence, retention, or requiring bladder management during or after surgical procedures. The global market for these devices is fundamentally driven by the escalating prevalence of urological disorders, particularly among the aging global demographic, and the increasing volume of surgical interventions necessitating temporary or long-term catheterization. According to the International Continence Society (ICS-EUS 2025 Abstract), in September 2025, the overall prevalence of urinary incontinence among U.S. women aged 20 and older was 63%, affecting an estimated 79.5 million women, underscoring a substantial and consistent demand for effective bladder management solutions.

Further market impetus stems from the rising incidence of chronic conditions such as diabetes and spinal cord injuries, alongside the growing emphasis on home healthcare and long-term care settings. However, a significant impediment to market expansion remains the persistent challenge of catheter-associated urinary tract infections, which present substantial clinical and economic burdens for healthcare systems globally.

Key Market Drivers

Increasing surgical procedures and hospital admissions represent a significant driver for the global urinary catheters market. The expanded volume of surgical interventions, whether elective or emergency, often necessitates temporary or extended bladder management, directly increasing demand for these devices. According to a publication from Wits University, referencing The Lancet in September 2025, the unmet need for surgical procedures has escalated to 160 million operations per year, underscoring a substantial and growing requirement for peri-operative and post-operative catheterization globally. This trend is further compounded by an aging global population, which experiences a higher incidence of conditions requiring surgical intervention, subsequently elevating hospital admissions and the need for catheter support.

Concurrently, advancements in catheter technology and design are propelling market expansion by addressing critical clinical challenges and improving patient outcomes. Innovations in materials, coatings, and design features reduce the risk of complications such as catheter-associated urinary tract infections and enhance patient comfort, thereby encouraging broader adoption. For instance, according to Coloplast's FY 2024/25 Full-Year Financial Results, released in November 2025, their Luja intermittent catheter, featuring Micro-hole Zone Technology, was a primary growth contributor, driving 8% organic growth in Continence Care. This continuous innovation fosters improved product efficacy and patient compliance. The impact of these drivers is evident across the market, with major players reporting robust performance; according to BD's Fourth Quarter and Full Year Fiscal 2025 Financial Results, released in November 2025, their Urology & Critical Care business unit within the BD Interventional segment achieved double-digit growth.

Download Free Sample Report

Key Market Challenges

Catheter-associated urinary tract infections (CAUTIs) stand as a significant impediment to the growth of the global urinary catheters market. These infections create substantial clinical and economic burdens for healthcare systems globally, directly hindering market expansion. CAUTIs frequently lead to extended hospital stays, the necessity for additional diagnostic tests, and expensive antibiotic treatment regimens, thereby redirecting financial resources that could otherwise be allocated to acquiring new or enhanced catheter technologies. This increased financial strain consequently influences purchasing decisions and can limit the broader adoption of catheter products.

Furthermore, concerns regarding patient safety due to the risk of CAUTIs can foster hesitation among both healthcare providers and patients to utilize urinary catheters, particularly when alternative bladder management options exist, thus affecting overall market demand. According to the Association of Professionals in Infection Control and Epidemiology (APIC) Conference in June 2025, one medical center successfully reduced CAUTI counts by 45% from 2022 to 2024, illustrating the substantial efforts and investments required to manage and prevent these complications. Such intensive focus on prevention underscores the direct negative impact CAUTIs have on market expansion by driving a preference for infection-resistant products and alternative solutions, rather than simply increasing the volume of traditional catheter sales.

Key Market Trends

The global urinary catheters market is significantly influenced by the growing adoption of home-based catheterization solutions, reflecting a broader shift towards patient-centric and outpatient care models. This trend empowers individuals with greater independence in managing urinary conditions outside traditional clinical settings, thereby driving demand for user-friendly and discreet catheter products. According to ConvaTec's 2025 full-year earnings, released in February 2026, its Continence Care segment experienced 6.6% organic growth, driven by increased volume in the USA and a broadening product portfolio that supports self-management. This expansion highlights the market's adaptation to patient preferences for convenient at-home use, which helps alleviate the burden on healthcare infrastructure.

Concurrently, advancements in antimicrobial and hydrophilic catheter coatings represent another pivotal trend, directly addressing the persistent challenge of catheter-associated urinary tract infections and enhancing patient comfort. These specialized coatings are crucial for improving biocompatibility and reducing bacterial adhesion, which extends dwell times and minimizes complications. Coloplast's Q1 2025/26 interim financial results, reported in February 2026, demonstrated a 7% organic sales growth in its Continence Care portfolio. This growth is partly attributable to ongoing innovation in product design, including advanced coating technologies that provide safer and more comfortable solutions for patients, fostering greater acceptance and longer-term usage of urinary catheters.

Segmental Insights

The Intermittent Catheters segment is experiencing rapid growth in the Global Urinary Catheters Market, primarily driven by their significant advantages in patient safety and quality of life. This growth stems from the reduced risk of urinary tract infections associated with their temporary use compared to indwelling catheters. Furthermore, advancements in design, such as hydrophilic coatings and ready-to-use formats, enhance patient comfort and promote greater independence through self-catheterization. The increasing global prevalence of urological conditions like urinary retention and neurogenic bladder disorders, coupled with an aging population, also substantially boosts demand for these effective and patient-friendly bladder management solutions.

Regional Insights

North America leads the global urinary catheters market, driven by its highly developed healthcare infrastructure and significant healthcare expenditure. The region exhibits a high prevalence of urological conditions and chronic diseases, such as urinary incontinence and benign prostatic hyperplasia, especially within its growing geriatric population, which necessitates increased catheter usage. Furthermore, favorable reimbursement policies and robust regulatory frameworks, exemplified by the U.S. Food and Drug Administration, encourage the adoption of advanced catheter technologies and innovation, ensuring patient safety and boosting market growth. This environment, coupled with high patient awareness, solidifies North America's dominant position.

Recent Developments

• In March 2026, FendX provided an update on its collaborative research with McMaster University regarding a specialized coating for Foley catheters. Initial laboratory testing for this breakthrough research demonstrated promising reductions in the growth of E. coli bacteria and exhibited strong durability. This development led to the filing of a provisional patent in August 2025, with FendX listed as the assignee. The company planned to engage a third-party laboratory for further expanded bacterial and durability testing to advance this innovative Foley catheter coating, with the catheter Collaborative Research Agreement extended to May 2026.
• In January 2026, Wellspect HealthCare launched its Surity™ Female External Catheter in the United States, marking the company's entry into a new continence care category. This non-invasive device was designed to support women experiencing severe urinary incontinence. The company stated that the product aimed to prevent leakage, protect skin integrity, and enable extended overnight use. It was made available for home purchase initially, with plans for availability in healthcare institutions to follow. Wellspect HealthCare also indicated intentions to release the Surity™ Urinary Management System and a male external catheter later that year.
• In November 2025, Cathetrix introduced Nephro-Safe, a new nephrostomy tube stabilizer, at MEDICA 2025. This product represented a significant advancement in catheter stabilization devices, designed to enhance patient safety by offering robust protection against infection, accidental dislodgement, and discomfort. Alongside Nephro-Safe, the company also showcased Foley-Safe, its innovative Foley catheter stabilizer featuring a three-layer protection system. This system included a strong adhesive patch for fixation, an anti-slide mechanism to reduce stress on the catheter, and a disconnection mechanism for safe removal in case of forceful pulling, setting a new standard in urological care.
• In November 2025, BD (Becton, Dickinson and Company) expanded its PureWick™ portfolio by launching the PureWick™ Portable Collection System. This new, discreet, battery-powered personal urine management device was specifically designed for wheelchair users, aiming to improve their mobility both within and outside the home. The non-invasive system leveraged gentle suction technology to draw urine away from the body into a collection canister, offering a more convenient solution for managing urinary incontinence. This innovation built upon the established success of the PureWick™ Urine Collection System, which was widely utilized in hospitals.

Key Market Players

• Hollister Incorporated
• Medtronic PLC
• Boston Scientific Corporation
• BD
• Cook Medical
• Convatec Inc
• Teleflex Incorporated
• Coloplast Corp
• B. Braun SE
• Medline Industries

Report Scope:

In this report, the Global Urinary Catheters Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Urinary Catheters Market , By Product:

• Intermittent Catheters
• Foley/ Indwelling Catheters
• External Catheters

• Urinary Catheters Market , By Application:

• Benign Prostate Hyperplasia & Prostate Surgeries
• Urinary Incontinence
• Spinal Cord Injury
• Others

• Urinary Catheters Market , By Type:

• Coated Catheters
• Uncoated Catheters

• Urinary Catheters Market , By End User:

• Hospital
• Clinics
• Long-Term Care Facilities
• Others

• Urinary Catheters Market , By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE